Hymson(SH:688559) Ge Long Hui·2025-09-30 07:37Core Viewpoint - The company is advancing its new medical business by developing an infrared femtosecond laser hair regeneration device, which has completed product application testing and laboratory validation [1] Group 1: Product Development - The company has established a product application testing platform for its self-developed infrared femtosecond laser hair regeneration device [1] - Laboratory and biological testing validations have been completed for the device [1] Group 2: Regulatory Progress - The company is actively pursuing the registration of Class III medical device certifications related to hair regeneration [1] - The certification process is nearing completion, indicating a potential market entry soon [1] Group 3: Market Collaboration - The company plans to collaborate closely with major public hospitals, private medical aesthetic institutions, and chain hair transplant organizations to promote the product's market application [1]